Raras
Buscar doenças, sintomas, genes...
Paralisia periódica tireotóxica
ORPHA:79102CID-10 · G72.3CID-11 · 5A02.YDOENÇA RARA

A paralisia periódica tireotóxica (TPP) é uma doença neurológica rara caracterizada por episódios recorrentes de paralisia e hipocalemia durante um estado tireotóxico.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A paralisia periódica tireotóxica (TPP) é uma doença neurológica rara caracterizada por episódios recorrentes de paralisia e hipocalemia durante um estado tireotóxico.

Publicações científicas
540 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Adult
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G72.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
9 sintomas
📏
Crescimento
4 sintomas
❤️
Coração
3 sintomas
🫘
Rins
2 sintomas
😀
Face
1 sintomas
🫃
Digestivo
1 sintomas

+ 20 sintomas em outras categorias

Características mais comuns

100%prev.
Hipertireoidismo
100%prev.
Hipocalemia episódica
100%prev.
Paresia hipocalêmica periódica
90%prev.
Hiperidrose
Muito frequente (99-80%)
90%prev.
Aumento de gotículas lipídicas intramiocelulares
Muito frequente (99-80%)
90%prev.
Tireotoxicose com bócio multinodular tóxico
Muito frequente (99-80%)
42sintomas
Muito frequente (21)
Frequente (10)
Ocasional (5)
Muito raro (6)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 42 características clínicas mais associadas, ordenadas por frequência.

HipertireoidismoHyperthyroidism
Muito frequente100%
Hipocalemia episódicaEpisodic hypokalemia
Muito frequente100%
Paresia hipocalêmica periódicaPeriodic hypokalemic paresis
Muito frequente100%
HiperidroseHyperhidrosis
Muito frequente (99-80%)90%
Aumento de gotículas lipídicas intramiocelularesIncreased intramyocellular lipid droplets
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico540PubMed
Últimos 10 anos200publicações
Pico202124 papers
Linha do tempo
2026Hoje · 2026🧪 2004Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial, Not applicable.

GABRA3Gamma-aminobutyric acid receptor subunit alpha-3Major susceptibility factor inRestrito
FUNÇÃO

Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:16412217, PubMed:29053855). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride an

LOCALIZAÇÃO

Postsynaptic cell membraneCell membrane

VIAS BIOLÓGICAS (1)
GABA receptor activation
MECANISMO DE DOENÇA

Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features

A neurologic disorder characterized by variable combinations of epileptic seizure, and a varying degree of intellectual disability and developmental delay. Some patients have dysmorphic facial features or mild skeletal anomalies. In general, males are more severely affected than females, although there is evidence for incomplete penetrance in both sexes.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
20.7 TPM
Brain Anterior cingulate cortex BA24
13.6 TPM
Hipotálamo
13.3 TPM
Córtex cerebral
12.6 TPM
Brain Nucleus accumbens basal ganglia
6.9 TPM
OUTRAS DOENÇAS (2)
epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic featuresthyrotoxic periodic paralysis
HGNC:4077UniProt:P34903
CACNA1SVoltage-dependent L-type calcium channel subunit alpha-1SCandidate gene tested inTolerante
FUNÇÃO

Pore-forming, alpha-1S subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Calcium channels containing the alpha-1S subunit play an important role in excitation-contraction coupling in skeletal muscle via their interaction with RYR1, which triggers Ca(2+) release from the sarcoplasmic reticulum and ultimately results in muscle contraction. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group

LOCALIZAÇÃO

Cell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (1)
NCAM1 interactions
MECANISMO DE DOENÇA

Periodic paralysis hypokalemic 1

An autosomal dominant disorder manifested by episodic flaccid generalized muscle weakness associated with falls of serum potassium levels.

VIAS REACTOME (1)
OUTRAS DOENÇAS (8)
congenital myopathy 18hypokalemic periodic paralysis, type 1malignant hyperthermia of anesthesiaobsolete periodic paralysis with transient compartment-like syndrome
HGNC:1397UniProt:Q13698
KCNJ18Inward rectifier potassium channel 18Major susceptibility factor inTolerante
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum

MECANISMO DE DOENÇA

Thyrotoxic periodic paralysis 2

A sporadic muscular disorder characterized by episodic weakness and hypokalemia during a thyrotoxic state. It is clinically similar to hereditary hypokalemic periodic paralysis, except for the fact that hyperthyroidism is an absolute requirement for disease manifestation. The disease presents with recurrent episodes of acute muscular weakness of the four extremities that vary in severity from paresis to complete paralysis. Attacks are triggered by ingestion of a high carbohydrate load or strenuous physical activity followed by a period of rest. Thyrotoxic periodic paralysis can occur in association with any cause of hyperthyroidism, but is most commonly associated with Graves disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
10.2 TPM
Skin Sun Exposed Lower leg
8.5 TPM
Testículo
1.2 TPM
Cérebro - Hemisfério cerebelar
0.1 TPM
Cerebelo
0.1 TPM
OUTRAS DOENÇAS (2)
thyrotoxic periodic paralysisthyrotoxic periodic paralysis, susceptibility to, 2
HGNC:39080UniProt:B7U540

Variantes genéticas (ClinVar)

3,409 variantes patogênicas registradas no ClinVar.

🧬 KCNJ18: NM_001194958.2(KCNJ18):c.1097A>G (p.Lys366Arg) ()
🧬 KCNJ18: NM_001194958.2(KCNJ18):c.1061C>T (p.Thr354Met) ()
🧬 KCNJ18: NM_001194958.2(KCNJ18):c.429del (p.Ile144fs) ()
🧬 CACNA1S: NM_000069.3(CACNA1S):c.5471A>G (p.Glu1824Gly) ()
🧬 CACNA1S: NM_000069.3(CACNA1S):c.4002T>C (p.Tyr1334=) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 656 variantes classificadas pelo ClinVar.

98
558
Patogênica (14.9%)
VUS (85.1%)
VARIANTES MAIS SIGNIFICATIVAS
CACNA1S: NM_000069.3(CACNA1S):c.530C>A (p.Ser177Ter) [Likely pathogenic]
CACNA1S: NM_000069.3(CACNA1S):c.1112del (p.Thr371fs) [Likely pathogenic]
CACNA1S: NM_000069.3(CACNA1S):c.1395del (p.Asp465fs) [Likely pathogenic]
CACNA1S: NM_000069.3(CACNA1S):c.11C>T (p.Ser4Phe) [Uncertain significance]
CACNA1S: NM_000069.3(CACNA1S):c.83C>G (p.Pro28Arg) [Uncertain significance]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Paralisia periódica tireotóxica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

2 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
204 papers (10 anos)
#1

Approach to the patient with severe hyperthyroidism-related complications.

The Journal of clinical endocrinology and metabolism2026 Mar 13

Hyperthyroidism is a prevalent endocrine disorder that can lead to severe multisystem complications, including atrial fibrillation (AF), thyrotoxic periodic paralysis (TPP), and thyroid storm (TS). This review discusses the pathophysiology, clinical presentation, and management challenges of these complications through illustrative clinical cases. AF is the most common cardiovascular manifestation, with restoration of euthyroidism and rate control being central to treatment. TPP presents with transient muscle weakness due to hypokalemia from intracellular potassium shift, requiring cautious potassium supplementation and hyperthyroidism control. TS is a life-threatening endocrine emergency characterized by multisystem decompensation, necessitating prompt multimodal therapy including antithyroid drugs, beta-blockers, corticosteroids, and supportive care. Thus, early recognition and tailored management remain the cornerstones of successful treatment for these severe complications of hyperthyroidism.

#2

Silent electrolyte imbalance unmasked by paralysis: a case of hypokalemia in a middle-aged woman.

Clinical biochemistry2026 Mar

Hypokalemic periodic paralysis is a rare autosomal dominant muscle channelopathy often misdiagnosed due to its atypical presentation. It is characterized by episodic flaccid paralysis with low serum potassium levels and may be triggered by factors such as high carbohydrate intake, infections, or medications. We report the case of a 25-year-old female who presented with acute ascending flaccid paralysis and was initially misdiagnosed with Guillain-Barré syndrome. Despite biochemical and electrocardiographic evidence of hypokalemia (serum K+: 2.7 mEq/L; electrocardiogram showing U waves and flattened T waves), potassium correction was not initiated. The patient rapidly deteriorated, required mechanical ventilation, and ultimately succumbed to her condition. Thyroid function testing was not performed despite clinical red flags, including a history of anxiety and depression, raising suspicion for thyrotoxic periodic paralysis. This case highlights the diagnostic challenges of hypokalemic paralysis, particularly when presenting as a neurological emergency without classic features. The failure to promptly correct hypokalemia and investigate its underlying etiology contributed to a preventable fatal outcome. A systematic "hypokalemia-first" approach is recommended to avoid such diagnostic delays in similar clinical settings. Timely recognition and correction of hypokalemia, alongside targeted evaluation of underlying causes such as thyrotoxicosis, are critical in patients presenting with acute flaccid paralysis. Standardized emergency protocols could significantly improve outcomes and prevent avoidable fatalities.

#3

Thyrotoxic periodic paralysis: diagnostic and management considerations.

BMJ case reports2025 Dec 12

Thyrotoxic periodic paralysis is a rare but potentially life-threatening complication of thyrotoxicosis characterised by hypokalaemia-induced flaccid paralysis due to an intracellular potassium shift rather than total body depletion. We report a male in his early 40s of Filipino origin who awoke with acute bilateral lower-limb weakness after he had consumed a large carbohydrate meal and performed strenuous exercise within the preceding 12 hours. Venous blood gas was normal; initial serum potassium was 1.7 mmol/L with phosphate 1.07 mmol/L. The ECG showed sinus tachycardia, first-degree atrioventricular block and prominent U-waves with QTc 388 ms. Urine potassium/creatinine ratio was 1.7 mmol/mmol (expected <2.0 in hypokalaemia), indicating appropriate renal conservation. A point-of-care thyroid panel did not include thyroid-stimulating hormone (TSH); the laboratory TSH was reported later as suppressed (0.001 mIU/L) with elevated FT4/FT3. There was no diuretic, insulin or β-agonist use. The patient received potassium chloride totalling 80 mEq (≤10 mEq/hour peripherally with continuous ECG monitoring) with serum potassium checks every 1-2 hour, and supplementation was stopped once K+ reached 4.0 mmol/L; propranolol 40 mg orally every 8 hours and methimazole 10 mg orally every 8 hours were started. Muscle strength normalised within 24 hours. This case underscores the diagnostic triad of hypokalaemia without an acid-base disorder, appropriate renal K+ conservation and characteristic ECG changes, and highlights pragmatic dosing/monitoring plus the need for definitive control of thyrotoxicosis to prevent recurrence.

#4

Generation of three iPSC lines from patients with CACNA1S related congenital myopathy.

Stem cell research2025 Oct

CACNA1S gene variants are associated with congenital myopathies (CMyo) with triad dysfunction (triadopathies), malignant hyperthermia susceptibility, hypokalemic periodic paralysis and thyrotoxic periodic paralysis. Here, we generated three iPSC lines derived from patients with CMyo linked to both autosomal dominant and recessive CACNA1S variants (CACNA1S-CMyo). The three lines displayed typical iPSC morphology, uniform expression of markers of the undifferentiated state, trilineage differentiation potential and normal karyotypes. As CACNA1S-CMyo are ultra-rare disorders, these lines enable a better in vitro characterization of CACNA1S pathophysiology and can be used to test different treatment approaches.

#5

The association between renin and thyroid-related biomarkers with clinical characteristics and outcomes in hyperthyroid patients.

Science progress2025

ObjectiveThere is crosstalk between the thyroid hormone and the renin-angiotensin-aldosterone system, but the clinical application is lacking. Our study aimed to verify the correlation between renin and other thyroid-related biomarkers and their association with treatment prognosis.MethodsThis retrospective study recruited eighty consecutive patients treated for hyperthyroidism in a medical center between 2021 and 2023. Among participants, 53 were newly diagnosed, and 27 were recurrent cases. Laboratory measurements, including renin, aldosterone, and other thyroid-related biomarkers, were assessed, while the associations of biomarkers and clinical symptoms were also analyzed. The clinical variables and biomarkers were entered into the Cox regression model to identify the independent risks associated with time to achieve euthyroidism.ResultsThe correlation matrix showed that free T4 was positively correlated either with T3 (r = 0.755, P < 0.001) or renin (r = 0.341, P = 0.002) but not with aldosterone (r = 0.055, P = 0.631). In ROC analysis for biomarkers and clinical symptoms, either free T4 (AUC = 0.754, P < 0.001) or thyroid-stimulating hormone receptor antibody (TSHRAb) (AUC = 0.645, P = 0.026) demonstrated effective prediction of tachycardia; however, renin was slightly positive for tachycardia without significance (AUC = 0.580, P = 0.233). Regarding thyrotoxic periodic paralysis, the renin showed significant prediction power (AUC = 0.727. P = 0.021) rather than free T4 (AUC = 0.543, P = 0.748) or TSHRAb (AUC = 0.688, P = 0.063). The median time to achieve euthyroidism was 166 days for newly onset patients and 216 days for recurrence, but the time-to-event curves showed no difference (log rank P = 0.728). Under Cox regression modeling, TSHRAb was found to independently predict late euthyroidism (Hazard ratio 0.946, 95% confidence interval 0.901-0.993, P = 0.026), and the renin had no impact (HR 0.995, 95% CI 0.987-1.003, P = 0.215).ConclusionsRenin but not aldosterone was positively correlated with free T4. Certain biomarkers measured at diagnosis were associated with hyperthyroid symptoms. Free T4 and TSHRAb might predict tachycardia, while renin might predict thyrotoxic periodic paralysis; nevertheless, only higher TSHRAb was associated with delayed euthyroid state achievement.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC430 artigos no totalmostrando 197

2026

Approach to the patient with severe hyperthyroidism-related complications.

The Journal of clinical endocrinology and metabolism
2026

Silent electrolyte imbalance unmasked by paralysis: a case of hypokalemia in a middle-aged woman.

Clinical biochemistry
2025

Thyrotoxic Periodic Paralysis (TPP): A Comprehensive Review with Regional Insights from the Middle East.

Cureus
2025

A Trajectory of Thyroid Function: From Thyrotoxic Paralysis to Post-ablative Hypothyroidism.

Cureus
2025

Thyrotoxic periodic paralysis: diagnostic and management considerations.

BMJ case reports
2025

Thyrotoxic Periodic Paralysis in an Asian Male With Graves' Disease.

Cureus
2025

Exploring Etiologies of Hypokalemic Paralysis: A Case Series.

The Journal of the Association of Physicians of India
2025

Guillain-Barré Syndrome and Viral Thyroiditis-Coexisting Together or Viral Thyroiditis as a Cause of Guillain-Barré Syndrome: An Unsolved Enigma!

The Journal of the Association of Physicians of India
2025

Hyperthyroid Hypokalemic Periodic Paralysis in a Nepali Male; A Case Report.

Clinical case reports
2025

Glucocorticoid-induced Thyrotoxic Periodic Paralysis Following Lumbar Nerve Root Block.

Internal medicine (Tokyo, Japan)
2025

Respiratory Failure in Hyperthyroidism: Focus on Thyrotoxic Periodic Paralysis.

Cureus
2025

Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study.

European thyroid journal
2025

Hypokalemic Paralysis Is Not Always Periodic: A Case Series.

Case reports in medicine
2025

Generation of three iPSC lines from patients with CACNA1S related congenital myopathy.

Stem cell research
2025

Hyperthyroidism in Disguise: A Case of New-Onset Atrial Fibrillation and Acute Reversible Paralysis.

JCEM case reports
2025

Refractory Ventricular Arrhythmias in Thyrotoxic Periodic Paralysis: An Uncommon Presentation of Cardiogenic Shock.

Cureus
2025

Silent Paralysis: Recurrent Thyrotoxic Periodic Paralysis in a Young Hispanic Male With Graves' Disease.

AACE endocrinology and diabetes
2025

Rebound Hyperkalemia After Potassium Repletion in Thyrotoxic Periodic Paralysis: A Case Report and Review of Management Implications.

Cureus
2025

Transient worsening of thyrotoxic myopathy following methimazole and metoprolol initiation in a 12-year-old girl: a case report and literature review.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Rebound Hyperkalemia in Hypokalemic Thyrotoxic Periodic Paralysis.

The Neurohospitalist
2025

Unveiling Thyrotoxic Periodic Paralysis: A Rare Hyperthyroid Complication.

Cureus
2025

The association between renin and thyroid-related biomarkers with clinical characteristics and outcomes in hyperthyroid patients.

Science progress
2025

Insulin-induced severe thyrotoxic periodic paralysis: A case report.

World journal of clinical cases
2025

A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis.

AACE clinical case reports
2025

Thyrotoxic periodic Paralysis With hypoxemia: A case report and a comprehensive review.

Radiology case reports
2025

"A Paralyzing Snack": An Endocrine Cause of Paralysis.

Acta medica (Hradec Kralove)
2024

Acute Muscle Weakness in Graves' Disease: A Case Report of Hypokalemic Thyrotoxic Periodic Paralysis.

Cureus
2024

Thyrotoxic Periodic Paralysis With Graves' Disease: A Case Report.

Cureus
2024

Thyrotoxic Periodic Paralysis: A Unique Case Highlighting the Diagnostic Challenges and Management.

Cureus
2024

Thyrotoxic Periodic Paralysis: A Rare Cause of Quadriparesis in a Young and Seemingly Healthy Patient.

Medicina (Kaunas, Lithuania)
2024

Periodic Paralysis: A Case Series with a Literature Review.

Case reports in neurology
2024

Thyrotoxic periodic paralysis - a retrospective study from Southern India.

European thyroid journal
2024

Familial hypokalemic periodic paralysis: a case induced by concurrent hyperthyroidism.

BMC nephrology
2024

Thyrotoxic periodic paralysis complicated by carbimazole-associated myositis.

BMJ case reports
2024

Unraveling the Clinical Complexity of Thyrotoxic Periodic Paralysis: A Case Report.

Cureus
2024

Thyrotoxic Periodic Paralysis in a Samoan Male With Metabolic Acidosis: A Case Report and Review of the Literature.

Cureus
2024

Coincident Thyrotoxic Hypokalemic Periodic Paralysis and Cardiomyopathy.

Journal of investigative medicine high impact case reports
2024

Thyrotoxic Periodic Paralysis: A Case Report with Patient Perspective.

Acute medicine
2024

A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.

PloS one
2024

Case report: thyrotoxic periodic paralysis, an unusual cause of hypokalemia.

Acta clinica Belgica
2024

Thyrotoxic periodic paralysis: a case report and review of relevant pathophysiology.

Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias
2024

Hyperandrogenism and Hypokalemic Thyrotoxic Periodic Paralysis in a North American Adolescent Girl.

JCEM case reports
2024

Atypical Normokalemic Case of Thyrotoxic Periodic Paralysis in a Pediatric Patient.

Cureus
2024

Thyrotoxic Periodic Paralysis, an Unusual Presentation of Paralysis After Spinal Surgery: A Case Report.

Cureus
2024

Recurrent Thyrotoxic Periodic Paralysis As the Sole Clinical Manifestation of Untreated Hyperthyroidism.

Cureus
2024

A Rare Case of Hypokalemic Periodic Paralysis With Acute Urinary Retention: Diagnosis and Management.

Cureus
2024

A rare case of thyrotoxic periodic paralysis revealing Graves' disease in a young Malian.

Clinical case reports
2024

Artificial Intelligence Electrocardiography Detecting Thyrotoxic Periodic Paralysis Following a SARS-CoV-2 Infection.

The American journal of medicine
2023

Thyrotoxic periodic paralysis presenting with quadriparesis and hyperreflexia.

BMJ case reports
2023

Graves' Disease With Initial Presentation of Thyrotoxic Periodic Paralysis.

Cureus
2023

A Thyrotoxic Periodic Paralysis Case Study: From Weakness to Wellness.

Cureus
2023

Thyrotoxic Periodic Paralysis as an Ongoing Diagnostic Challenge: A Case Report and Literature Review.

Cureus
2023

Hypokalemic Hypophosphatemic Thyrotoxic Periodic Paralysis Associated with Bipolar Disorder Therapy.

Cureus
2023

Thyrotoxic Periodic Paralysis With Hypokalemia: A Case Study.

Cureus
2023

Code Pseudo Stroke - A Case of Hypokalaemic Periodic Paralysis Mimicking Stroke.

European journal of case reports in internal medicine
2023

Thyrotoxic periodic paralysis as the first presentation of Graves' disease: A case report.

Clinical case reports
2023

An Interesting Case of Weakness and Atrial Tachycardia in the Emergency Department: Thinking Beyond Hearts and Minds.

Cureus
2023

Gitelman syndrome with Graves' disease leading to rhabdomyolysis: a case report and literature review.

BMC nephrology
2023

Thyrotoxic periodic paralysis in a Caucasian man without identifiable genetic predisposition: a case report.

Thyroid research
2023

Thyrotoxic periodic paralysis: a rare cause of periodic paralysis - a case report.

Annals of medicine and surgery (2012)
2023

Thyrotoxic Periodic Paralysis With Severe Hypokalemia Precipitated by Acute Alcohol Intoxication in a Patient With Graves' Disease.

Cureus
2023

A Case of Thyrotoxic Periodic Paralysis: "I Can't Move!".

Cureus
2023

Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.

The lancet. Diabetes &amp; endocrinology
2023

Thyrotoxic periodic paralysis associated with lactic metabolic acidosis: Case report of an African man and review of literature.

Annales d'endocrinologie
2023

High-dose intravenous hydrocortisone for the treatment of hyperthyroidism: a rare precipitant of thyrotoxicosis periodic paralysis.

Endocrinology, diabetes &amp; metabolism case reports
2022

Case report: SCN4A p.R1135H gene variant in combination with thyrotoxicosis causing hypokalemic periodic paralysis.

Frontiers in neurology
2023

Thyrotoxic Periodic Paralysis: An Under-Recognized Cause of Paralysis in Young Hispanic Men.

The Journal of emergency medicine
2022

Thyrotoxic Periodic Paralysis: The Peril of Potassium Replacement.

Cureus
2023

Unique Presentation of Thyrotoxic Periodic Paralysis With Urticarial Dermographia.

Military medicine
2022

Thyrotoxic Periodic Paralysis: Case Presentation With Tetraparesis and Cardiac Dysrhythmia.

Cureus
2022

Thyrotoxic periodic paralysis-still a diagnostic challenge.

Proceedings (Baylor University. Medical Center)
2022

Thyrotoxic Periodic Paralysis: An Unusual Cause of Quadriparesis.

Cureus
2022

Intravenous Iodinated Contrast Induced Thyrotoxic Periodic Paralysis: A Case Report.

Case reports in endocrinology
2022

Thyrotoxic periodic paralysis in a patient with Graves' disease: A case report.

Annals of medicine and surgery (2012)
2022

[Clinical-epidemiological profile of patients with thyrotoxic periodic paralysis in two peruvian hospitals].

Revista medica del Instituto Mexicano del Seguro Social
2022

Case report: Hyperthyroid hypokalemic periodic paralysis.

Annals of medicine and surgery (2012)
2022

Subacute thyroiditis associated with thyrotoxic periodic paralysis after COVID-19 vaccination: a case report.

Endocrinology, diabetes &amp; metabolism case reports
2022

Acute Flaccid Tetraparesis after COVID-19 Infection: Think of the Thyroid.

Case reports in medicine
2022

[Muscle weakness in the extremities in a man with Graves' disease].

Ugeskrift for laeger
2022

When cardiology meets endocrinology: sustained atrial flutter associated with thyrotoxic periodic paralysis.

Oxford medical case reports
2022

Electrocardiographic Manifestation in Thyrotoxic Periodic Paralysis.

Cureus
2022

Thyrotoxic periodic paralysis (TPP): assessment in the emergency department.

BMJ case reports
2021

Acute myocarditis presenting as accelerated junctional rhythm in Graves' disease: A case report.

World journal of clinical cases
2021

"I'm so weak I feel paralyzed. Can you help me?" A case on thyrotoxic periodic paralysis.

Journal of the American College of Emergency Physicians open
2021

Thyrotoxic periodic paralysis presenting as a broad complex tachycardia.

British journal of hospital medicine (London, England : 2005)
2021

Thyrotoxic periodic paralysis in two sexagenarian men: A case report.

Medicine
2021

An Unusual Presentation of Thyrotoxicosis: Leg Weakness and Hypokalemia in a 21-Year-Old Male.

Case reports in endocrinology
2021

Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder.

Endocrinology, diabetes &amp; metabolism case reports
2021

Recurrent thyrotoxic periodic paralysis with normokalemia in a 36-year-old man: A case report.

Clinical case reports
2021

Ventricular Fibrillation: A Rare Initial Presentation of Thyrotoxic Periodic Paralysis.

JACC. Case reports
2021

Thyrotoxic Periodic Paralysis: A Case Report and Literature Review.

Clinical medicine &amp; research
2021

Chronic Alcohol Abuse-Induced Hypokalemia Might Lead to Delayed Diagnosis or Misdiagnosis of Thyrotoxic Periodic Paralysis.

Cureus
2021

Artificial Intelligence-Assisted Electrocardiography for Early Diagnosis of Thyrotoxic Periodic Paralysis.

Journal of the Endocrine Society
2021

Hypokalemic Periodic Paralysis Precipitated by Thyrotoxicosis and Renal Tubular Acidosis.

Case reports in endocrinology
2021

A Case of Hypokalemic Periodic Paralysis in a Young Athlete.

Cureus
2021

Recurrent, refractory hypokalemia as a diagnostic clue to thyrotoxic periodic paralysis in a patient with acute kidney injury and suspected Guillain-Barre syndrome.

Clinical case reports
2021

Thyrotoxic Periodic Paralysis in a Young Hispanic Male With Newly Diagnosed Grave's Disease.

Cureus
2021

Ventricular tachycardia secondary to thyrotoxic periodic paralysis: A case report.

Journal of electrocardiology
2021

Peripheral nerve dysfunction in a patient with thyrotoxic periodic paralysis: Evidence from an axonal prolonged exercise test.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2021

Thyrotoxic Periodic Paralysis.

The New England journal of medicine
2021

Thyrotoxic Periodic Paralysis with Thyroid Storm as the First Presentation of Graves' disease; a Case Report.

Archives of academic emergency medicine
2021

Retracted: Thyrotoxic Periodic Paralysis: Clinical Challenges.

Journal of thyroid research
2021

Thyrotoxic Periodic Paralysis Causing Back Pain and Leg Weakness: An Unusual Presentation of Hyperthyroidism.

Case reports in endocrinology
2021

Noninvasive ventilator prevents intubation in thyrotoxic hypokalemic periodic paralysis-associated respiratory failure: A case report and literature review.

Tzu chi medical journal
2021

Thyrotoxic periodic paralysis in an adolescent male: A case report and literature review.

Clinical case reports
2020

Thyrotoxic Periodic Paralysis and Complicated Thyrotoxicosis, Two Presentations of Hyperthyroidism with Notable Differences in their Clinical Manifestations: An Experience from a Tertiary Care Hospital in the United States.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2020

Thyrotoxic periodic paralysis after urethral dilatation.

Avicenna journal of medicine
2020

Thyrotoxic Periodic Paralysis- A Diagnostically Challenging Rare Clinical Entity.

Cureus
2020

Thyrotoxic Muscle Paralysis as a Rare Cause of Reversible Muscle Weakness: A Case Report.

Cureus
2020

Genome-wide meta-analysis reveals novel susceptibility loci for thyrotoxic periodic paralysis.

European journal of endocrinology
2020

A Literature Review on Thyrotoxic Periodic Paralysis.

Cureus
2020

THYROTOXIC PERIODIC PARALYSIS IN A COMPETITIVE BODYBUILDER WITH THYROTOXICOSIS FACTITIA.

AACE clinical case reports
2020

Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves' disease patients with thyrotoxic periodic paralysis.

Journal of clinical &amp; translational endocrinology
2022

Prolonged Exercise Test in Patients With History of Thyrotoxicosis.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
2020

Thyrotoxic Hypokalemic Periodic Paralysis Triggered by Dexamethasone Administration.

Acta medica (Hradec Kralove)
2020

Association study in Mexican patients with thyrotoxic hypokalemic periodic paralysis.

Biomedical reports
2020

Thyrotoxic Periodic Paralysis-A Misleading Challenge in the Emergency Department.

Diagnostics (Basel, Switzerland)
2020

Thyrotoxic Periodic Paralysis With Features of Andersen-Tawil Syndrome: A Case Report and Literature Review.

Cureus
2020

Thyrotoxic periodic paralysis presenting in an African-American teenage male: case report.

International journal of pediatric endocrinology
2019

Thyrotoxic Periodic Paralysis with Hypokalemia in an Adult Male from Nepal: A Case Report.

JNMA; journal of the Nepal Medical Association
2020

Unusual Clinical Presentation of Periodic Paralysis: Case Report and Literature Review.

Cureus
2020

Analysis of the genetic background associated with sporadic periodic paralysis in Japanese patients.

Journal of the neurological sciences
2020

Further evidence for shared genetic susceptibility in both sporadic and Thyrotoxic periodic paralysis.

Journal of the neurological sciences
2020

Thyrotoxic Periodic Paralysis: An Incidental Diagnosis!

Cureus
2020

Thyrotoxic periodic paralysis: A retrospective, observational study from India.

The Indian journal of medical research
2020

Periodic Paralysis Syndromes: A T3 Thyrotoxicosis Case and Review of Literature.

HCA healthcare journal of medicine
2019

HYPOKALEMIC PERIODIC PARALYSIS IN A PATIENT WITH EUTHYROID GRAVES DISEASE AND CELIAC DISEASE.

AACE clinical case reports
2021

Low-dose oral propranolol for treatment of thyrotoxic periodic paralysis with hypokalaemia in the emergency department: A case report.

Journal of clinical pharmacy and therapeutics
2019

A rare case of hypokalemic ventricular tachycardia in a patient with thyrotoxic periodic paralysis.

International journal of critical illness and injury science
2019

Thyrotoxic Periodic Paralysis: A Spine Consultation.

Journal of the American Academy of Orthopaedic Surgeons. Global research &amp; reviews
2020

Sudden Night Palsy in a Young Man: Thyrotoxic Periodic Paralysis as a First Manifestation of Hyperthyroidism.

The American journal of medicine
2020

PharmGKB summary: very important pharmacogene information for CACNA1S.

Pharmacogenetics and genomics
2019

Hypokalemic Periodic Paralysis as the First Manifestation of Thyrotropin-Secreting Pituitary Adenoma.

Case reports in endocrinology
2019

Contribution of Asian Haplotype of KCNJ18 to Susceptibility to and Ethnic Differences in Thyrotoxic Periodic Paralysis.

The Journal of clinical endocrinology and metabolism
2019

Thyrotoxic hypokalemic periodic paralysis due to Graves' disease in 2 adolescents.

Annals of pediatric endocrinology &amp; metabolism
2019

Don't Trip Over the Trop: An Unusual Presentation of Thyrotoxic Periodic Paralysis.

The American journal of medicine
2019

Assessment of Molecular Subtypes in Thyrotoxic Periodic Paralysis and Graves Disease Among Chinese Han Adults: A Population-Based Genome-Wide Association Study.

JAMA network open
2019

Thyrotoxic periodic paralysis with ventricular tachycardia.

Journal of electrocardiology
2019

Clinical and Etiological Spectrum of Hypokalemic Periodic Paralysis in a Tertiary Care Hospital in Pakistan.

Cureus
2019

[Muscle weakness with hypokalemia and hyperthyroidism in an adolescent with Down syndrome].

Archivos argentinos de pediatria
2018

Thyroxine-induced periodic paralysis: a rare complication of nutritional supplements.

BMJ case reports
2018

A Rare Case of Thyrotoxic Periodic Paralysis After Epidural Steroid Injection: A Case Report and Literature Review.

The American journal of case reports
2018

Periodic paralysis with normokalemia in a patient with hyperthyroidism: A case report.

Medicine
2019

Thyrotoxic periodic paralysis complicated by life-threatening acute hypercapnic respiratory failure in a Chinese male with painless thyroiditis.

The American journal of emergency medicine
2018

Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review.

BMC endocrine disorders
2019

Hypokalemic thyrotoxic periodic paralysis. Report of one case.

Medicina clinica
2018

Thyrotoxic periodic paralysis: case report and review of the literature.

Electronic physician
2019

Lift Then Shift: Thyrotoxic Periodic Paralysis.

The American journal of medicine
2018

Thyrotoxic Periodic Paralysis and Cardiomyopathy in a Patient with Graves' Disease.

Cureus
2018

Graves' Disease Presenting with Periodic Paralysis to the Emergency Department.

Case reports in endocrinology
2018

An atypical presentation of high potassium renal secretion rate in a patient with thyrotoxic periodic paralysis: a case report.

BMC nephrology
2018

Does thyrotoxic periodic paralysis have a genetic predisposition? A case report.

Annals of clinical biochemistry
2018

Changing Management Guidelines in Thyrotoxic Hypokalemic Periodic Paralysis.

The Journal of emergency medicine
2018

Bilateral Lower Extremity Paralysis in a Caucasian Male Presenting to the Emergency Department.

Case reports in emergency medicine
2018

Steroids and Thyrotoxicosis Precipitate Periodic Paralysis.

Cureus
2018

Thyrotoxic Periodic Paralysis as a Presentation of Thyrotoxicosis: A Case Report and review of the literature.

Mediterranean journal of rheumatology
2017

Analysis of Clinical and Metabolic Profile of Acute Neuromuscular Weakness Related to Hypokalemia.

Acta neurologica Taiwanica
2017

Thyrotoxic Channelopathies.

The Journal of the Association of Physicians of India
2017

Novel lincRNA Susceptibility Gene and Its Role in Etiopathogenesis of Thyrotoxic Periodic Paralysis.

Journal of the Endocrine Society
2017

Thyrotoxic periodic paralysis: an unusual presentation of hyperthyroidism.

The Netherlands journal of medicine
2017

De novo Mutation in CACNA1S Gene in a 20-Year-Old Man Diagnosed with Metabolic Myopathy.

Archives of Iranian medicine
2017

Persistent severe hypokalemia: Gitelman syndrome and differential diagnosis.

Jornal brasileiro de nefrologia
2017

Long Exercise Test in the Interattack Period of Periodic Paralysis: A Useful and Sensitive Diagnostic Tool.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
2017

Periodic Paralysis and Encephalopathy as Initial Manifestations of Graves' Disease: Case Report and Review of the Literature.

The neurologist
2017

Thyrotoxic periodic paralysis: a case study and review of the literature.

Journal of community hospital internal medicine perspectives
2017

Thyrotoxic periodic paralysis as an initial presentation of Graves' disease in a Saudi patient.

BMJ case reports
2017

Thyrotoxic periodic paralysis: A case report.

International journal of health sciences
2017

Normokalemic Thyrotoxic Periodic Paralysis with Acute Resolution in the Emergency Department.

Clinical practice and cases in emergency medicine
2017

A rare cause of thyrotoxic periodic paralysis: liquorice consumption.

Postgraduate medical journal
2017

Paralysis that easily reverses: a case of thyrotoxic periodic paralysis.

BMJ case reports
2017

Down-regulation of Kir2.6 channel by c-termini mutation D252N and its association with the susceptibility to Thyrotoxic Periodic Paralysis.

Neuroscience
2016

An Unusual Case of Acute Muscle Weakness.

Acute medicine
2017

Hypokalemic Paralysis Complicated by Concurrent Hyperthyroidism and Hyperaldosternoism: A Case Report.

The American journal of case reports
2017

Association of KCNJ2 Genetic Variants with Susceptibility to Thyrotoxic Periodic Paralysis in Patients with Graves' Disease.

Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
2017

Is thyrotoxic periodic paralysis a disease caused by muscle membrane dysfunction?

Muscle &amp; nerve
2017

Lower-Extremity Weakness in a Teenager Due to Thyrotoxic Periodic Paralysis.

The Journal of emergency medicine
2016

Steroid-induced thyrotoxic periodic paralysis during Graves' ophthalmopathy treatment.

Postgraduate medical journal
2016

A novel Kir2.6 mutation associated with hypokalemic periodic paralysis.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2016

Thyrotoxic Periodic Paralysis: A Concise Review of the Literature.

Current rheumatology reviews
2016

Whole genome and exome sequencing realignment supports the assignment of KCNJ12, KCNJ17, and KCNJ18 paralogous genes in thyrotoxic periodic paralysis locus: functional characterization of two polymorphic Kir2.6 isoforms.

Molecular genetics and genomics : MGG
2016

Novel susceptibility gene for nonfamilial hypokalemic periodic paralysis.

Neurology
2016

Hypokalaemic Periodic Paralysis in a Patient with Subclinical Hyperthyroidism: A Rare Case.

Journal of clinical and diagnostic research : JCDR
2016

A Case of Nonfatal Ventricular Arrhythmia Due to Thyrotoxic Periodic Paralysis in a Saudi Patient as an Initial Presentation of Graves' Disease.

Clinical medicine insights. Case reports
2016

Thyrotoxic Periodic Paralysis: A Puzzling Case of Chest Pain and Weakness.

Advanced emergency nursing journal
2016

Thyrotoxic Periodic Paralysis and Polymorphisms of the ADRB2, AR, and GABRA3 Genes in Men with Graves Disease.

Endocrinology and metabolism (Seoul, Korea)
2016

Periodic Paralysis as a New Phenotype of Resistance to Thyroid Hormone Syndrome in a Chinese Male Adult.

The Journal of clinical endocrinology and metabolism
2015

Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition.

Cureus
2015

Paralysis as a Presenting Symptom of Hyperthyroidism in an Active Duty Soldier.

U.S. Army Medical Department journal
2015

Size of quadriceps femoris may contribute to thyrotoxic periodic paralysis.

Medical hypotheses
2015

Hypokalemic Paralysis Complicated by Concurrent Hyperthyroidism and Chronic Alcoholism: A Case Report.

Medicine
2015

Muscle paralysis in thyrotoxicosis.

BMJ case reports
2015

A case of thyrotoxic periodic paralysis with respiratory failure in an African American woman.

American journal of critical care : an official publication, American Association of Critical-Care Nurses
2015

The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis.

BMC neurology
2015

Normokalemic thyrotoxic periodic paralysis with preserved reflexes- a unique case report.

Journal of clinical and diagnostic research : JCDR
2015

Thyrotoxic periodic paralysis in long standing graves' disease: an unusual presentation with normokalemia.

North American journal of medical sciences
2015

A rare case of thyrotoxic periodic paralysis precipitated by hydrocortisone.

Journal of natural science, biology, and medicine
2015

Sudden flaccid paralysis.

BMJ case reports
Ver todos os 430 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Paralisia periódica tireotóxica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Paralisia periódica tireotóxica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Approach to the patient with severe hyperthyroidism-related complications.
    The Journal of clinical endocrinology and metabolism· 2026· PMID 41823424mais citado
  2. Silent electrolyte imbalance unmasked by paralysis: a case of hypokalemia in a middle-aged woman.
    Clinical biochemistry· 2026· PMID 41616965mais citado
  3. Thyrotoxic periodic paralysis: diagnostic and management considerations.
    BMJ case reports· 2025· PMID 41386979mais citado
  4. Generation of three iPSC lines from patients with CACNA1S related congenital myopathy.
    Stem cell research· 2025· PMID 40885023mais citado
  5. The association between renin and thyroid-related biomarkers with clinical characteristics and outcomes in hyperthyroid patients.
    Science progress· 2025· PMID 40420828mais citado
  6. Paralysis to Analysis: Unmasking Thyrotoxic Periodic Paralysis in a Middle-Aged Male Patient With Undiagnosed Graves Disease.
    Cureus· 2026· PMID 41960015recente
  7. Unmasking Hypokalemic Periodic Paralysis: The Rare Role of Levothyroxine in a Pakistani Woman.
    AACE Endocrinol Diabetes· 2026· PMID 41938294recente
  8. Thyrotoxic Paralysis in a Hispanic Woman: An Unusual Presentation of a Neurological Emergency.
    Cureus· 2026· PMID 41883915recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79102(Orphanet)
  2. MONDO:0019201(MONDO)
  3. GARD:10814(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Paralisia periódica tireotóxica
Compêndio · Raras BR

Paralisia periódica tireotóxica

ORPHA:79102 · MONDO:0019201
Prevalência
<1 / 1 000 000
Herança
Multigenic/multifactorial, Not applicable
CID-10
G72.3 · Paralisia periódica
CID-11
Início
Adult
Prevalência
0.0 (Europe)
MedGen
UMLS
C0268446
EuropePMC
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades